Published in Cancer Res on April 15, 2001
Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res (2009) 1.84
DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev (2008) 1.68
Relationship of DNA methylation and gene expression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2014) 1.63
Environmental epigenetics of asthma: an update. J Allergy Clin Immunol (2010) 1.53
Molecular biology of lung cancer: clinical implications. Clin Chest Med (2011) 1.47
Environmental epigenetics: prospects for studying epigenetic mediation of exposure-response relationships. Hum Genet (2012) 1.47
Retracted DNA methylation-associated inactivation of TGFbeta-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers. Br J Cancer (2005) 1.45
Chromium cross-links histone deacetylase 1-DNA methyltransferase 1 complexes to chromatin, inhibiting histone-remodeling marks critical for transcriptional activation. Mol Cell Biol (2007) 1.31
Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients. Neoplasia (2006) 1.22
Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC). BMC Cancer (2011) 1.19
Beyond genetics: epigenetic code in chronic kidney disease. Kidney Int (2010) 1.18
Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos. J Toxicol Environ Health B Crit Rev (2011) 1.14
Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma. Carcinogenesis (2008) 1.14
Epigenetics: connecting environment and genotype to phenotype and disease. J Dent Res (2009) 1.13
Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles. Cancer Res (2009) 1.12
Potential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy. Curr Genomics (2009) 1.11
Significant impact of promoter hypermethylation and the 540 C>T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase. Am J Pathol (2002) 1.11
K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking. Pancreas (2007) 1.10
Environmental epigenetics and its implication on disease risk and health outcomes. ILAR J (2012) 1.10
RUNX3 methylation reveals that bladder tumors are older in patients with a history of smoking. Cancer Res (2008) 1.05
The prognostic value of epigenetic silencing of p16 gene in NSCLC patients: a systematic review and meta-analysis. PLoS One (2013) 1.04
Epigenomics in environmental health. Front Genet (2011) 1.02
High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families. J Med Genet (2014) 1.01
Dysregulated transcriptional and post-translational control of DNA methyltransferases in cancer. Cell Biosci (2014) 1.00
Frequent expression of new cancer/testis gene D40/AF15q14 in lung cancers of smokers. Br J Cancer (2002) 0.98
Formation and repair of tobacco carcinogen-derived bulky DNA adducts. J Nucleic Acids (2010) 0.98
DNA methylation changes associated with risk factors in tumors of the upper aerodigestive tract. Epigenetics (2012) 0.97
Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma. Cell Cycle (2013) 0.96
Aberrant methylation in non-small cell lung cancer. Surg Today (2010) 0.96
Tumor-suppressor Gene Promoter Hypermethylation in Saliva of Head and Neck Cancer Patients. Transl Oncol (2012) 0.96
Epigenetics of lung cancer. Transl Res (2014) 0.95
Epigenetics in non-small cell lung cancer: from basics to therapeutics. Transl Lung Cancer Res (2016) 0.94
DNA methylation in lung tissues of mouse offspring exposed in utero to polycyclic aromatic hydrocarbons. Food Chem Toxicol (2017) 0.94
The relationship between aberrant methylation and survival in non-small-cell lung cancers. Br J Cancer (2004) 0.93
Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation. Carcinogenesis (2013) 0.92
Association of promoter methylation with histologic type and pleural indentation in non-small cell lung cancer (NSCLC). Diagn Pathol (2011) 0.91
Lung cancer and its association with chronic obstructive pulmonary disease: update on nexus of epigenetics. Curr Opin Pulm Med (2011) 0.89
Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers. BMC Cancer (2007) 0.88
DNA methylation: its role in cancer development and therapy. Curr Probl Cancer (2008) 0.88
Key epigenetic changes associated with lung cancer development: results from dense methylation array profiling. Epigenetics (2012) 0.88
Epigenomics of idiopathic pulmonary fibrosis. Epigenomics (2012) 0.88
Cigarette smoking and p16INK4α gene promoter hypermethylation in non-small cell lung carcinoma patients: a meta-analysis. PLoS One (2011) 0.87
The significance of epigenetic alterations in lung carcinogenesis. Mol Biol Rep (2012) 0.86
CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancer. J Thorac Oncol (2013) 0.86
Hypermethylation of p16INK4a in Korean non-small cell lung cancer patients. J Korean Med Sci (2007) 0.86
Methylation of the DLEC1 gene correlates with poor prognosis in Japanese lung cancer patients. Oncol Lett (2010) 0.85
Epigenetic therapy in lung cancer. Front Oncol (2013) 0.85
Epigenetics of idiopathic pulmonary fibrosis. Transl Res (2014) 0.83
HOXA11 hypermethylation is associated with progression of non-small cell lung cancer. Oncotarget (2013) 0.82
The DNMT3B -579 G>T promoter polymorphism and risk of lung cancer. Exp Ther Med (2011) 0.82
Causes and Consequences of Age-Related Changes in DNA Methylation: A Role for ROS? Biology (Basel) (2014) 0.81
INK4 Family -A promising target for 'gene-regulating chemoprevention' and 'molecular-targeting prevention' of cancer. Environ Health Prev Med (2005) 0.81
Epigenetic inactivation of heparan sulfate (glucosamine) 3-O-sulfotransferase 2 in lung cancer and its role in tumorigenesis. PLoS One (2013) 0.79
DAPK1 Promoter Methylation and Cervical Cancer Risk: A Systematic Review and a Meta-Analysis. PLoS One (2015) 0.79
Correlation between smoking history and molecular pathways in sporadic colorectal cancer: a meta-analysis. Int J Clin Exp Med (2015) 0.78
Long-term exposure to hexavalent chromium inhibits expression of tumor suppressor genes in cultured cells and in mice. J Trace Elem Med Biol (2012) 0.78
Promoter hypermethylation using 24-gene array in early head and neck cancer: better outcome in oral than in oropharyngeal cancer. Epigenetics (2014) 0.78
Different susceptibility of increased DNMT1 expression by exposure to tobacco smoke according to histology in primary non-small cell lung cancer. J Cancer Res Clin Oncol (2006) 0.77
Promoter Methylation of CDKN2A, RARβ, and RASSF1A in Non-Small Cell Lung Carcinoma: Quantitative Evaluation Using Pyrosequencing. Tuberc Respir Dis (Seoul) (2012) 0.77
The Impact of External Factors on the Epigenome: In Utero and over Lifetime. Biomed Res Int (2016) 0.77
Genetic and epigenetic tumor suppressor gene silencing are distinct molecular phenotypes driven by growth promoting mutations in nonsmall cell lung cancer. J Cancer Epidemiol (2009) 0.76
Molecular profile of lung cancer in never smokers. EJC Suppl (2013) 0.76
Feasibility of using an epigenetic marker of risk for lung cancer, methylation of p16, to promote smoking cessation among US veterans. BMJ Open Respir Res (2014) 0.75
Dose- and time- effect responses of DNA methylation and histone H3K9 acetylation changes induced by traffic-related air pollution. Sci Rep (2017) 0.75
In Utero Cigarette Smoke Affects Allergic Airway Disease But Does Not Alter the Lung Methylome. PLoS One (2015) 0.75
p16 controls epithelial cell growth and suppresses carcinogenesis through mechanisms that do not require RB1 function. Oncogenesis (2017) 0.75
Azacitidine and decitabine have different mechanisms of action in non-small cell lung cancer cell lines. Lung Cancer (Auckl) (2010) 0.75
The Impact of Genomic Profiling for Novel Cancer Therapy - Recent Progress in Non-Small Cell Lung Cancer. J Genet Genomics (2015) 0.75
Cigarette smoke condensate and individual constituents modulate DNA methyltransferase expression in human liver cells. SAGE Open Med (2015) 0.75
Identification of DLC-1 expression and methylation status in patients with non-small-cell lung cancer. Mol Clin Oncol (2015) 0.75
Cigarette Smoking and the Risk of Adult Myeloid Disease: A Meta-Analysis. PLoS One (2015) 0.75
Effect of combined 5-aza-2'deoxycytidine and cisplatin treatment on the P15 lung adenocarcinoma cell line. Oncol Lett (2015) 0.75
Assessment of methylation status of locoregional lymph nodes in lung cancer using EBUS-NA. Clin Exp Metastasis (2015) 0.75
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A (2001) 24.34
Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice. Ann Oncol (2011) 3.55
Solitary fibrous tumors of the pleura: eight new cases and review of 360 cases in the literature. Cancer (1981) 3.44
Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J Exp Med (1994) 3.02
Cerebral vasoconstriction and stroke after use of serotonergic drugs. Neurology (2002) 2.89
Early age at smoking initiation and tobacco carcinogen DNA damage in the lung. J Natl Cancer Inst (1999) 2.88
CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. J Exp Med (1994) 2.88
Expression cloning of a protective Leishmania antigen. Science (1995) 2.83
Constructing polycompetitor cDNAs for quantitative PCR. J Immunol Methods (1993) 2.62
Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation (1991) 2.62
Postintubation tracheal stenosis. Treatment and results. J Thorac Cardiovasc Surg (1995) 2.61
Requirement of tissue-selective TBP-associated factor TAFII105 in ovarian development. Science (2001) 2.59
Association of heart rate variability with occupational and environmental exposure to particulate air pollution. Circulation (2001) 2.46
Is air pollution a risk factor for low birth weight in Seoul? Epidemiology (2001) 2.38
Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology (1992) 2.27
Clinical practices in the management of new-onset, uncomplicated, low back workers' compensation disability claims. J Occup Environ Med (1999) 2.18
APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci U S A (1996) 2.18
Gamma-glutamyltransferase and diabetes--a 4 year follow-up study. Diabetologia (2003) 2.14
Inflammatory pseudotumors of the lung: progression from organizing pneumonia to fibrous histiocytoma or to plasma cell granuloma in 32 cases. Hum Pathol (1988) 2.11
Reinforced primary repair of thoracic esophageal perforation. Ann Thorac Surg (1995) 2.09
Antisense suppression of phospholipase D alpha retards abscisic acid- and ethylene-promoted senescence of postharvest Arabidopsis leaves. Plant Cell (1997) 2.07
Pulmonary arteriovenous malformations: therapeutic options. Ann Thorac Surg (1993) 2.03
Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis (2000) 1.97
Body mass index is associated with the development of acute respiratory distress syndrome. Thorax (2009) 1.96
Mycobacterium abscessus infection in cystic fibrosis. Colonization or infection? Am J Respir Crit Care Med (2000) 1.94
Diet, physical activity, and colorectal cancer among Chinese in North America and China. J Natl Cancer Inst (1990) 1.92
Management of acquired nonmalignant tracheoesophageal fistula. Ann Thorac Surg (1991) 1.91
Cotton dust and endotoxin exposure-response relationships in cotton textile workers. Am Rev Respir Dis (1987) 1.84
Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis. J Immunol (2000) 1.84
Interleukin-10 polymorphism in position -1082 and acute respiratory distress syndrome. Eur Respir J (2006) 1.82
Urinary 1-hydroxypyrene and polycyclic aromatic hydrocarbon exposure among asphalt paving workers. Ann Occup Hyg (2004) 1.78
Bronchogenic carcinoma with chest wall invasion. Ann Thorac Surg (1991) 1.64
Association of cigarette smoking and asbestos exposure with location and histology of lung cancer. Am J Respir Crit Care Med (1998) 1.64
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells. Oncogene (2007) 1.58
Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis (1995) 1.57
Genetic susceptibility to benzene and shortened gestation: evidence of gene-environment interaction. Am J Epidemiol (2000) 1.52
Gene deletion of glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev (1995) 1.51
Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res (2001) 1.50
Pulmonary responses to oil fly ash particles in the rat differ by virtue of their specific soluble metals. Toxicol Sci (1998) 1.50
Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J Natl Cancer Inst (1999) 1.50
Medical surveillance of hazardous materials response fire fighters: a two-year prospective study. J Occup Environ Med (1997) 1.50
Management of tumors of the trachea. Oncology (Williston Park) (1992) 1.50
Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J Clin Invest (1996) 1.49
Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy. Ann Intern Med (1986) 1.48
Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc Natl Acad Sci U S A (1994) 1.47
Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma. Ophthalmology (1998) 1.46
PM(10) exposure, gaseous pollutants, and daily mortality in Inchon, South Korea. Environ Health Perspect (1999) 1.46
Correlates of fitness for duty in hazardous materials firefighters. Am J Ind Med (1999) 1.44
Galectin-1 prolongs survival of mouse liver allografts from Flt3L-pretreated donors. Am J Transplant (2013) 1.44
Mucoepidermoid lung tumors. Ann Thorac Surg (1989) 1.43
Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev (1996) 1.43
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Inhaled nitric oxide for adult respiratory distress syndrome after pulmonary resection. Ann Thorac Surg (1998) 1.41
Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians. Cancer Epidemiol Biomarkers Prev (1998) 1.39
Human lymphocytes exposed to low doses of ionizing radiations become refractory to high doses of radiation as well as to chemical mutagens that induce double-strand breaks in DNA. Int J Radiat Biol Relat Stud Phys Chem Med (1988) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Air pollution and daily mortality in seven major cities of Korea, 1991-1997. Environ Res (2000) 1.39
Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma. Arch Pathol Lab Med (1990) 1.38
Fitness for duty evaluations in hazardous materials firefighters. J Occup Environ Med (1998) 1.38
A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res (1998) 1.38
Comparison of dietary habits, physical activity and body size among Chinese in North America and China. Int J Epidemiol (1994) 1.37
Physical map of the genome of Rhodobacter capsulatus SB 1003. J Bacteriol (1992) 1.37
A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead. Environ Health Perspect (1995) 1.37
Treatment strategies for bronchopleural fistula. J Thorac Cardiovasc Surg (1995) 1.37
Phylogeny of Vibrio cholerae based on recA sequence. Infect Immun (2000) 1.37
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Associations between genome-wide Native American ancestry, known risk alleles and B-cell ALL risk in Hispanic children. Leukemia (2013) 1.33
Review of processing and analysis methods for DNA methylation array data. Br J Cancer (2013) 1.33
Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and delta-aminolevulinic acid dehydratase genes. Environ Health Perspect (2001) 1.33
Determination of total arsenic concentrations in nails by inductively coupled plasma mass spectrometry. Biol Trace Elem Res (1999) 1.32
Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy. Br J Cancer (1997) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation. Am J Physiol (1998) 1.32
Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study. Cancer Res (1998) 1.30
Associations of tibial lead levels with BsmI polymorphisms in the vitamin D receptor in former organolead manufacturing workers. Environ Health Perspect (2000) 1.29
Aberrant methylation of p16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer. Cancer Epidemiol Biomarkers Prev (1999) 1.29
Pulmonary adenocarcinomas of the fetal lung type: a clinicopathologic study indicating differences in histology, epidemiology, and natural history of low-grade and high-grade forms. Am J Surg Pathol (1998) 1.28
Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer. Oncogene (2001) 1.28